University of Wisconsin–Madison

Deprescribing in the Older Adult

A pharmacist counsels her patient about his prescription medication.There is a positive correlation between number of medications and rates of falls and adverse drug events leading to hospitalizations. Older adults are at risk for falls and adverse events due to a high average number of medications.  More often than not, medications are added to patient regimens when a new symptom appears. 

This webinar focuses on tools for appropriately deprescribing medications that are no longer indicated or have a potential to cause harm.

Developed & Conducted by the Pharmacy Society of Wisconsin
in cooperation with the Division of Pharmacy Professional Development, Pharmacy Society of WI logo
School of Pharmacy, University of Wisconsin-Madison and the United Way.

Registration Information

Register

Refund Policy

Course date:Jun 1, 2018 - May 31, 2020
Location:
Course fee:

There is no cost associated with this webinar.

Course Objectives

Course Objectives

Following this presentation, you will be able to:

  1. Define polypharmacy
  2. State three of the potential negative outcomes from polypharmacy
  3. State the risk factors associated with adverse drug events
  4. Cite at least two models used to safely deprescribe
  5. Describe how to identify opportunities for safely deprescribing in a medication regimen
  6. Describe the role of the older adult in deprescribing
  7. Define your role as a facilitator in assisting the deprescribing of unnecessary medications to reduce the risk for harm

Course Outline

Instructors

Alan Lukazewski, RPh, Director of Clinical Pharmacy, Neugen Healthcare, Madison, WI

Planning Committee

Tim Bartholow, MD, VP, Chief Medical Officer, WEA Trust, Madison, WI
Eric Buxton, PhD, UW-Madison, School of Pharmacy, Madison, WI
Alan Lukazewski, RPh, Director of Clinical Pharmacy, Neugen Healthcare, Madison, WI
Kari Trapskin, PharmD, Pharmacy Society of Wisconsin, Madison, WI

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin School of Pharmacy and School of Nursing that the faculty, authors, planners, and other persons who may influence content of this activity disclose all relevant financial relationships with commercial interests in order to allow staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made in the activity handout materials.

CE Credit

ICEP LogoAccreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin–Madison ICEP designates this a knowledge based activity for 0.75 hours or 0.075 CEUs of CPE credit. Credit can be earned by successfully completing the activity, the assessment and the evaluation. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

UAN: JA0000358-9999-19-014-H04-P,  (0.75 Hour or 0.075 CEUs)

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this online activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Units (CEUs)

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.075 CEUs or .75 hours.

Program Coordinator

Eric Buxton, PhD

Division of Pharmacy Professional Development
777 Highland Avenue
Madison, WI 53705
(608) 262-2431 FAX
(608) 265-2259
eric.buxton@wisc.edu